It’s a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies

Abstract Background Targeted alpha therapy represents an advanced and rapidly evolving form of precision cancer treatment with increasing importance in recent years. The alpha-emitter 225Ac plays a key role in this clinical development due to its attractive physical and chemical properties. In this...

Full description

Saved in:

Bibliographic Details
Main Authors:	Johanna Trommer, Martin Ullrich, Falco Reissig, Santiago Andres Brühlmann, Anne-Kathrin Nitt-Weber, Zbynek Novy, Katarina Hajduova, Daniela Kurfurstova, Romana Hendrychova, Jan Bouchal, Milos Petrik, Christin Neuber, Wiebke Sihver, Sven Stadlbauer, Jens Pietzsch, Martin Kreller, Klaus Kopka, Constantin Mamat, Kristof Zarschler
Format:	Article
Language:	English
Published:	SpringerOpen 2025-06-01
Series:	EJNMMI Radiopharmacy and Chemistry
Subjects:	133La 225Ac Macropa Targeted alpha therapy TAT Single-domain antibody Theranostics
Online Access:	https://doi.org/10.1186/s41181-025-00354-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

It’s a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies

Similar Items